From Investing.com: 2024-11-18 11:05:29

CVS Health adds four new board members, including Glenview Capital’s Larry Robbins, to improve operations and shareholder value. Shares rise 2% to $54.30. Glenview has a 0.95% stake in CVS, with Third Point and Sachem Capital also holding stakes. Analysts believe changes won’t drastically alter CVS’s direction. Steve Nelson appointed to lead Aetna business. David Joyner replaces Karen Lynch as CEO. Glenview supports Lynch’s resignation. Robbins, a constructivist shareholder, pushes for changes without advocating for CVS breakup. Three other Glenview executives join CVS board. Total board members now at 16.



Read more at Investing.com: CVS adds four new board members in deal with Glenview Capital By Reuters